MARKET

LGVN

LGVN

Longeveron Inc
NASDAQ
1.350
-0.090
-6.25%
After Hours: 1.410 +0.06 +4.44% 18:00 05/14 EDT
OPEN
1.410
PREV CLOSE
1.440
HIGH
1.430
LOW
1.340
VOLUME
63.31K
TURNOVER
--
52 WEEK HIGH
6.40
52 WEEK LOW
0.7707
MARKET CAP
20.26M
P/E (TTM)
-0.5160
1D
5D
1M
3M
1Y
5Y
1D
Longeveron: Strategic Advancements and Promising Developments Drive Buy Rating
TipRanks · 1d ago
Weekly Report: what happened at LGVN last week (0505-0509)?
Weekly Report · 2d ago
Longeveron® Named XPRIZE Healthspan Semifinalist and Top 40 Milestone 1 Award Recipient
Barchart · 2d ago
Longeveron Reports Q1 2025 Progress and Financials
TipRanks · 5d ago
Longeveron Inc. Reports Financial Results for the Quarter Ended March 31, 2025
Press release · 6d ago
Press Release: Longeveron(R) Announces First Quarter 2025 Financial Results and Provides Business Update
Dow Jones · 6d ago
Roth MKM Remains a Buy on Longeveron (LGVN)
TipRanks · 05/06 13:48
Weekly Report: what happened at LGVN last week (0428-0502)?
Weekly Report · 05/05 11:37
More
About LGVN
More
Longeveron Inc. is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs. The Company’s lead investigational product is Lomecel-B, an allogeneic medicinal signaling cell (MSC) therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B has multiple potential mechanisms of action, encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. The Company is pursuing three pipeline indications: hypoplastic left heart syndrome (HLHS), Alzheimer’s disease, and Aging-related Frailty. Lomecel-B development programs have received five distinct FDA designations: for the HLHS program - Orphan Drug designation, Fast Track designation, and Rare Pediatric Disease designation; and, for the AD program - Regenerative Medicine Advanced Therapy (RMAT) designation and Fast Track designation.
Recently
Symbol
Price
%Change

Webull offers Longeveron Inc stock information, including NASDAQ: LGVN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LGVN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LGVN stock methods without spending real money on the virtual paper trading platform.